Alpine Woods Capital Investors, LLC Crispr Therapeutics Ag Transaction History
Alpine Woods Capital Investors, LLC
- $626 Million
- Q3 2024
A detailed history of Alpine Woods Capital Investors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 5,730 shares of CRSP stock, worth $238,310. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,730Holding current value
$238,310% of portfolio
0.04%Shares
13 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
57.5MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$330 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$312 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$124 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$123 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$116 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.24B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....